<DOC>
	<DOCNO>NCT02537743</DOCNO>
	<brief_summary>Evaluation patient report outcome ( PRO ) regard typical ailment REAL LIFE Renal Cell Carcinoma population</brief_summary>
	<brief_title>Prospective Patient Reported Outcomes ( PRO ) Registry Patients With Advanced Renal Cell Carcinoma</brief_title>
	<detailed_description>The PRO Kidney project recruit representative cohort patient advance renal cell carcinoma ( RCC ) treat systemic antiproliferative therapy TKIs , mTOR inhibitor , cytokine , antiVEGF immune therapy . The aim study collect data effectiveness patientsÂ´quality life preference real life set . Patient Reported Outcomes ( PRO ) assess questionnaire consist Functional Assessment Cancer Therapy ( FACT ) Kidney Syndrome Index 19 ( FKSI 19 ) complete four question assess ailment change skin hands/feet , taste , color hair mouth score . 13 Questions Fatigue assess Functional Assessment Chronic IIlness Disease .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<criteria>Histologically confirm renal cell carcinoma Start first line systemic treatment Ability read understand German Written inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Patient Reported Outcomes</keyword>
</DOC>